secwatch / observer
8-K filed November 13, 2023, 6:59 PM ET ticker MYGN CIK 0000899923
other material confidence high sentiment neutral materiality 0.65

Myriad Genetics raises ~$110M via public offering of 6.47M shares at $17/sh

MYRIAD GENETICS INC

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

MYRIAD GENETICS INC entered into Underwriting Agreement with Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC (effective 2023-11-08).

Action
entry
Agreement
underwriting
Counterparty
Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC
Effective
2023-11-08
Exact text from the filing
On November 8, 2023, Myriad Genetics, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC (the “Underwriters”), relating to the issuance and sale pursuant to an underwritten public offering (the “Offering”) of an aggregate of 6,470,588 shares (the “Shares”) of its common stock, par value $0.01 per share (the “Common Stock”), and up to 970,588 additional shares of Common Stock at the Underwriters’ option.
View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

MYRIAD GENETICS INC filing history →

Source: SEC EDGAR
accession 0000899923-23-000110
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.